The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $65.34

Today's change-1.66 -2.48%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $65.34

Today's change-1.66 -2.48%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.

Cyberonics Inc down (U.S.)$1.66

Cyberonics Inc closed sharply lower Monday, dropping (U.S.)$1.66 or 2.48% to (U.S.)$65.34. Over the last five days, shares have gained 1.65% and 17.35% year to date. Shares have outperformed the S&P 500 by 15.41% during the last year.

Key company metrics

  • Open(U.S.) $66.90
  • Previous close(U.S.) $67.00
  • High(U.S.) $67.14
  • Low(U.S.) $65.02
  • Bid / Ask(U.S.) $0.00 / (U.S.) $69.87
  • YTD % change+17.35%
  • Volume249,466
  • Average volume (10-day)595,379
  • Average volume (1-month)383,955
  • Average volume (3-month)353,391
  • 52-week range(U.S.) $48.19 to (U.S.) $76.48
  • Beta0.89
  • Trailing P/E30.49×
  • P/E 1 year forward23.81×
  • Forward PEG1.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.14
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.88%

Based on its net profit margin of 18.88%, Cyberonics Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 24, 201507/24/2015Apr 24, 201504/24/2015Jan 23, 201501/23/2015Oct 24, 201410/24/2014
Revenue81747273
Total other revenue--------
Total revenue81747273
Gross profit72666667
Total cost of revenue9877
Total operating expense62574847
Selling / general / administrative34303130
Research & development10111111
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)990--
Other operating expenses, total--------
Operating income19172426
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax19172426
Income after tax12111717
Income tax, total7679
Net income12111717
Total adjustments to net income--------
Net income before extra. items12111717
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items12111717
Inc. avail. to common incl. extra. items12111717
Diluted net income12111717
Dilution adjustment--------
Diluted weighted average shares26262627
Diluted EPS excluding extraordinary itemsvalue per share0.470.400.620.64
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.690.610.620.64